secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOLYTICS BIOTECH INC (ONCY)
CIK:        0001129928
Form:       8-K
Filed at:   2026-07-24T20:40:18+00:00
Accession:  0001129928-26-000047
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncolytics Biotech receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received Nasdaq letter on July 20, 2026, for non-compliance with $1.00 minimum bid price rule.
- Common stock closed below $1.00 for 30 consecutive business days; ticker ONCY remains listed.
- 180-day compliance period ends January 19, 2027; must close at $1.00+ for 10 consecutive days.
- If not cured, may qualify for additional 180-day period if other listing standards are met.
- Company will monitor bid price and assess options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1129928/000112992826000047/0001129928-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1129928/000112992826000047/oncy-20260720.htm
  HTML page:      https://secwatch.observer/filing/0001129928-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer